1. Refereed Articles and Book Chapters
Farisco, M. Baldassarre, G., Cartoni. E., Leach, A., Petrovici, M., Rosemann, A., Salles, A., Stahl, B., Van Albada, S. (2024). A method for the ethical analysis of brain-inspired AI. Artificial Intelligence Review. DOI: https://arxiv.org/abs/2305.10938
Rosemann, A. & S. Molyneux-Hodgson (2023). Challenge-driven innovation and responsible innovation: dynamics and disconnects, Journal of Responsible Innovation, 10(1), DOI: 10.1080/23299460.2023.2286762.
Ogoh, G., Akintoye, S., Eke, D., Farisco, M., Fernow, J., Grasenick, K., Guerrero, M., Roseman, A., Salles, A., and Ulnicane, I. (2023). Developing Capabilities for Responsible Research and Innovation. Journal of Responsible Technology, DOI: https://doi.org/10.1016/j.jrt.2023.100065
Rosemann, A., and Zhang, X.Q. (2022) Exploring the social, ethical, legal, and responsibility dimensions of artificial intelligence for health - a new column in Intelligent Medicine, Intelligent Medicine, 2(2), p.103-109, DOI: https://doi.org/10.1016/j.imed.2021.12.002 (Journal Article)
Stahl, B.C., Akintoye, S., Bitsch, L., Bringedal, B., Eke, D., Farisco, M., Grasenick, K., Guerrero, M., Knight, W., Leach, T., Nyholm, S., Ogoh, G., Rosemann, A., Salles, A., Trattnig, J., Ulnicane. I. (2021) From Responsible Research and Innovation to responsibility by design, Journal of Responsible Innovation, DOI: 10.1080/23299460.2021.1955613 (Journal Article)
Rosemann, A. and S. Molyneux-Hodgson (2020) Industrial Biotechnology: To what extent is Responsible Innovation on the Agenda?, Trends in Biotechnology, Doi: 10.1016j.tibtech.2019.07.006 (Journal Article)
Rosemann, A., and S. Molyneux-Hodgson (2020) The National Industrial Biotechnology Strategy to 2030: What role for responsible research and innovation? The Biochemist. Weblink: Part 1 and Part 2. (Digital Publication)
Rosemann, A., Balen, A., Nerlich, B., Hauskeller, C., Sleeboom-Faulkner, M., Hartley, S., X.Q. Zhang and N. Lee (2019) Heritable human gene editing in global perspective: national and international policy challenges. Hastings Centre Report, 49(3), 31-42. (Journal Article)
Rosemann, A. (2019). Alter-standardizing clinical trials: The gold standard in the cross-fire, Science as Culture, 28(2), 125-146. (Journal Article)
Rosemann, A., Vasen, F. and G. Bortz (2019). Global Diversification in Medicine Regulation: Insights from Regenerative Stem Cell Medicine, Science as Culture, 38(2), 223-249. (Journal Article)
Bortz, G., Rosemann, A., and F. Vasen (2019). Shaping Stem Cell Therapies in Argentina: Regulation, Risk Management and Innovation Policies, Sociologias, 21(50), 116-155. (Journal Article)
Rosemann, A. (2019) Balancing social justice and risk management in the governance of gene drive technology: lessons from stem cell research. In: Hauskeller, C., Manzeschke, A., and A. Pichl (Eds). The Matrix of Stem Cell Research Revisited. London and New York: Routledge. (Book Chapter)
Nerlich, B. and A. Rosemann (2019) Towards a global dialogue about heritable germline editing: Mapping needs and challenges. BioMed Central – On Society Blog (July 23, 2019). (Digital Publication/Blog)
Rosemann, A. and B. Nerlich (2019). Heritable Germline Editing: National and International Governance Challenges and Policy Options. Making Science Public Blog (July 27, 2019). (Digital Publication/Blog)
Rosemann, A. and H.Y. Luo (2018) Attitudes on the Donation of Human Embryos for Stem Cell Research among Chinese IVF Patients and Students. Journal of Bioethical Inquiry. Doi.org/10.1007/s11673-018-9862-9. (Journal Article)
Rosemann, A., Bortz, G., and F. Vasen (2018). Regulatory developments for non-hematopoietic stem cell therapeutics: perspectives from the EU, the USA, Japan, China, India, Argentina and Brazil. In: X.D. Chen (ed.) A Roadmap to non-Hematopoietic Stem Cell-based Therapeutics: From the Bench to the Clinic. New York: Elsevier Academic Press. (Book Chapter)
Jiang, L. and A. Rosemann (2018) Human embryo gene editing in China: the uncertain legal status of the embryo, Biosocieties. Doi.org/10.1057/s41292-018-0116-1 (Journal Article)
Sleeboom-Faulkner, M., Chen, H.D. and Rosemann, A. (2018) Regulatory capacity building and the governance of clinical stem cell research in China, Science and Public Policy. Doi/10.1093/scipol/scx077/4675127 (Journal Article)
Rosemann, A., Jiang, L. and X.Q. Zhang (2018). The Regulatory and Legal Situation of Human Embryo, Gamete and Germ Line Gene Editing Research and Clinical Applications in the People’s Republic of China. Background Paper; commissioned by Nuffield Council on Bioethics (Report)
Rosemann, A., Barfoot, J. and C. Blackburn (2017) Special Focus Issue on Regenerative Medicine in Society: Interdisciplinary Perspectives (Part I) – Foreword. Regenerative Medicine, 12(6), 577-580. https://doi.org/10.2217/rme-2017-0117 (Journal Article)
Barfoot, J., A. Rosemann and C. Blackburn (2017) Special Focus Issue on Regenerative Medicine in Society: Interdisciplinary Perspectives (Part II) – Foreword. Regenerative Medicine, 12(7), 733-736. https://doi.org/10.2217/rme-2017-0136 (Journal Article)
Bortz, G., Vasen, F. and A. Rosemann (2017) Entre oportunidad y riesgo. Regulación, expectativas y políticas CTI para células madre en Argentina. Ciencia, Docencia y Tecnología, 54, 38-74. (Journal Article)
Rosemann, A., L. Jiang and X.Q. Zhang (2017) Human Germ Line Gene Editing: Why comparative, cross-national studies on public viewpoints are important. Anthropology, http://dx.doi.org/10.4172/2332-0915.1000175 (Journal Article)
Pham, P.V., and A. Rosemann (2017) Safety, Ethics and Regulation - Preface. In: Pham, P.V. and A. Rosemann (eds.) Stem Cells in Clinical Applications: Safety, Ethics and Regulations. Heidelberg and New York: Springer(Book Chapter)
Rosemann, A., Zhang Z.Q., Sui, S.L., Ely, A., and Sleeboom-Faulkner, M. (2017) The regulatory situation for clinical stem cell research in China. In: Pham, P.V. and A. Rosemann (eds.) Stem Cells in Clinical Applications: Safety, Ethics and Regulations. Heidelberg and New York: Springer, 275-290. (Book Chapter)
Rosemann, A. (2017) Contested Tissues: the donation of oocytes and embryos in the IVF-Stem Cell Interface in China. In: Pham, P.V. and A. Rosemann (eds.) Stem Cells in Clinical Applications: Safety, Ethics and Regulations. Heidelberg and New York: Springer, 291-300. (Book Chapter)
Rosemann, A. (2017) Challenges to international stem cell clinical trials in countries with divergent regulations. In: Pham, P.V. and A. Rosemann (eds.) Stem Cells in Clinical Applications: Safety, Ethics and Regulations. Heidelberg and New York: Springer, 301-319. (Book Chapter)
Rosemann, A. (2017) The Regulation of Clinical Stem Cell Research and Applications: three dynamics of global regulatory diversification (in three parts). Regenerative Medicine Network (RegMedNet). Spotlight to Cell Therapy Regulation (June 30, 2017). Weblink: Part 1, Part 2, Part 3. (Digital Publication/Blog)
Rosemann, A. and N. Chaisinthop (2016) The pluralization of the international: networks of resistance and alter-standardization in regenerative stem cell medicine. Social Studies of Science, 46(1), 112-39. (Journal Article)
Rosemann, A., Bortz, G., Vasen, F., and M. Sleeboom-Faulkner (2016) Global regulatory developments for clinical stem cell research: diversification and challenges to collaborations, Regenerative Medicine, 11(7), 647-657. (Journal Article)
Sleeboom-Faulkner, M. Chekar, C. Faulkner, A. Heitmeyer, C., Marouda, M. Rosemann, A, et al. (2016) National Home-Keeping and the Regulation of Translational Stem Cell Applications: An international perspective, Social Science & Medicine, 153, 240-249 (Journal Article)
Rosemann, A. and M. Sleeboom-Faulkner (2016) New regulation for clinical stem cell research in China – expected impact and challenges for implementation, Regenerative Medicine, Doi:10.2217/rme.15.80 (Journal Article)
Rosemann, A. (2015) Stem cell treatments for neurodegenerative diseases: challenges from a science, business and healthcare perspective, Neurodegenerative Disease Management, 5(2), 85-87. (Journal Article)
Rosemann, A. (2015) Multi-country Stem Cell Trials: the Need for an International Support Structure, Stem Cell Research, 14(3), 396-400. (Journal Article)
Rosemann, A. (2014) Standardization as situation-specific achievement: Regulatory diversity and the production of value in intercontinental collaborations in stem cell medicine, Social Science & Medicine, 122, 72-80. (Journal Article)
Rosemann, A. (2014) 'Modalities of value, exchange, solidarity: the social life of stem cells in China', in: M. Sleeboom-Faulkner (Ed.) Stem Cell Research in Asia: Looking beyond regulatory exteriors. London/New York: Routledge. (Book Chapter)
Rosemann, A. (2014) Why regenerative stem cell medicine progresses slower than expected, Journal of Cellular Biochemistry, 15(12), 2073-2076. (Journal Article)
Rosemann, A. (2013) Scientific Multipolarization: Its impact on international clinical research collaborations and theoretical implications, Science Technology and Society, 18(3), 339-359. (Journal Article)
Rosemann, A. (2013) Medical Innovation and National Experimental Pluralism: Insights from Clinical Stem Cell Research and Applications in China, BioSocieties, 8(1), 58-74. (Journal Article)
Rosemann, A. (2011) Modalities of Value, Exchange, Solidarity: Exploring the Social Life of Stem Cells in China, New Genetics and Society, 30(2), 181-192. (Journal Article)
Rosemann, A. (2010) 'The IVF-Stem Cell Interface in China: Ontologies, Value-perceptions and Donation-practices of Embryonic Forms of Life ', in O. Doering (ed.), Life Sciences in Translation - A Sino-European Dialogue on Ethical Governance of the Life Sciences, BIONET, Online Textbook, Brussels: European Commission, 168-179. (Book Chapter)
Rosemann, A. (2009) `Life without Value? Listening to the voices of embryo donors for human embryonic stem cell research in China', The Newsletter, International Institute of Asian Studies, No 52, winter 2009, 15-6. (URL: http://sro.sussex.ac.uk/53217/). (Digital Publication/Blog)
2. Special Issues, Article Collections and Books
Rosemann, A. (2019) ‘Alter-standardizing Clinical Trials: Implications for Policy and Practice’, Special Issue, Science as Culture, 28(2), 122 – 263.
Rosemann, A., Barfoot, J., and C. Blackburn (2017) 'Regenerative Medicine in Society: Interdisciplinary Perspectives (Part 1)', Regenerative Medicine, 12(6), 577-731 [September issue 2017].
Barfoot, J., Rosemann, A., and C. Blackburn (2017) 'Regenerative Medicine in Society: Interdisciplinary Perspectives (Part 2)', Regenerative Medicine, 12(7), 733-892 [October issue 2017]
Pham, P.V., and A. Rosemann (2017) Stem Cells in Clinical Applications (Volume 6): Safety, Ethics and Regulation. Heidelberg and New York: Springer Nature (Series Editor: Phuc Van Pham). ISBN 978-3-319-591643.
3. Policy Reports and Research briefings
Rosemann, A., Farisco, M., Leach. T., A. Salles (2023) Handbook for RRI for adaptive networks for cognitive architectures. https://zenodo.org/record/7763281 (Research Report, p. 1 - 37)
Rosemann, A., Farisco, M., Leach. T., A. Salles (2023) Technology Transfer, Commercialisation, and IPR of brain-inspired AI innovations - Practical, Ethical and Governance Challenges in the Transition to a Post-HBP Future; (Commissioner Report by the European Commission, p 1–18)
Bitsch, L., Salles, A., Evers, K., Changeux, […], Rosemann, A, […] Rommelfanger, K. (2023). Ethics and Society in Brain Research: Implementing Responsible Research and Innovation (RRI) in the Human Brain Project (HBP). Zenodo. https://doi.org/10.5281/zenodo.10068344 (Research Report, p. 1 - 39)
Rosemann, A., Farisco, M., Leach. T., A. Salles (2023) Key Findings from the Ethical Analysis of Issues Related tothe Exploitation, Transfer and Commercialisation of AI-related Research Outcomes in the HBP and EBRAINS (Research Brief for HBP and EBRAINS, p. 1-17)
Rosemann, A., Kgwadi, B., Zwart, H., Adams, A., Agu, C., Archibong, U., Dalton, G., De Castro, F., Eshareturi, C., Kaul, N., Novella Abril, I., Sanches De Madariaga, I., Utam, U. K., Wakunuma, K., & A. Tash (2021) Mapping the UNESCO Recommendations on Science and Scientific Researchers to the UN Sustainable Development Goals, in collaboration with UNESCO, Zenodo, DOI: https://doi.org/10.5281/zenodo.5584841 (Report, p. 1-134)
Rosemann, A., and K. Wakunuma (2021) Responsible Research and Innvoation Networked Globally: Focus Analysis of the Role of Industry Innovators; Zenodo, Doi: https://doi.org/10.5281/zenodo.5025433 (Research Report, p 1-50)
Aicardi, C., Bitsch, L., Datta Burton, S., Evers, K., Farisco, M., Mahfoud, T., Rose, N., Rosemann, A., Salles, A., Stahl, B. C. & I. Ulnicane (2020) Opinion on Trust and Transparency in Artificial Intelligence, Ethics and Society, Human Brain Project E-Library; DOI: https://zenodo.org/record/7763281 (Report, p. 1 - 36)
Rosemann, A. (2017) Germ Line Gene Editing in Global Context: Challenges and Needs from a UK Perspective; report for the Nuffield Council of Bioethics's Working Party: “Genome Editing in Human Reproduction.”
Rosemann, A., Barfoot, J., Price-Evans, A. and C. Blackburn (2017). Regenerative Medicine in Society – Introduction to the Digital Gateway. EuroStemCell (Digital Publication)
Rosemann, A. (2015) ’Clinical stem cell research collaborations between China and the USA: opportunities, challenges, possible solutions’, client: Don Reed, Palo Alto, CA, USA (Californians for Cure; Sponsor of Roman Reed Spinal Cord Injury Research Act; CA)
Rosemann, A., Zhang XQ., Sui SS., Su YY, and A. Ely (2013) 'Country Report: Stem Cell Research in China'; working paper series, Centre for Bionetworking, University of Sussex.
Rosemann, A. (2011) `Contextualizing Experimental Stem Cell Applications in China'; Report: Department of Regulatory Affairs, Western Institutional Review Board, Olympia, USA.
Rosemann, A. (2011) ‘Ethical Strategies in Stem Cell Banking: UK and Taiwan in cross-national Perspective', Report: submitted to: Taiwan Stem Cell Bank, Hsinchu, Taiwan.
4. Educational Resources:
Human Brain Project (2023) Ethics and RRI dimensions of commercialization and knowledge transfer. (with Guillermo Velasco). Website.
University of Warwick (2018). Human Germline Gene Editing in Global Context. Project Website
EuroStemCell (2017). A Digital Gateway: Regenerative Medicine in Society. EuroStemCell Website; Co-production with Jan Barfoot, Adam Price-Evans, Ryan Lewis, Anna Couturier, and Clare Blackburn of the University of Edinburgh. (This Educational Resource comprises 27 short contributions of leading inter-disciplinary scholars written for patients, practitioners, and the wider public).
Rosemann, A. (2013) ‘Stem Cell Clinical Trials’, Centre for Bionetworking, Educational Resource (URL: http://sro.sussex.ac.uk/53219/)